Cognition Therapeutics GAAP EPS of -$0.11 misses by $0.01

2 hours ago 1

Cognition Therapeutics press release (NASDAQ:CGTX): Q2 GAAP EPS of -$0.11 misses by $0.01.
Cash, cash equivalents, and restricted cash equivalents as of June 30, 2025 were approximately $11.6 million and total obligated grant funds remaining from the National Institute of Aging, a division of the

Recommended For You